Palliative Pharmacotherapy for Cardiovascular Disease
Published: July 01, 2024
- Palliative care is important in managing cardiovascular disease (CVD), as it reduces physical symptom burden, manages emotional and spiritual distress, supports caregivers, and helps patients make decisions aligned with their goals of care.
- Palliative pharmacotherapy, including cardiovascular and common palliative medicines, can be used throughout the clinical course of CVD to control symptoms and improve quality of life.
- Deprescribing is an essential component of palliative care for individuals with multiple chronic conditions, including CVD.
Supporting Materials
- Commentary: Patient-centered Symptom Management and Cardiovascular Treatment by Lyndsay DeGroot, PhD, RN, CNE; David B. Bekelman, MD, MPH
- Top Things to Know: Palliative Pharmacotherapy for Cardiovascular Disease
Recommended Reading
- News Release: Palliative care beneficial to manage symptoms, improve quality of life for people with CVD
- 2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy
- 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease
- 2023 Guideline for the Diagnosis and Management of Atrial Fibrillation
- 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure
- Drugs That May Cause or Exacerbate Heart Failure Palliative Care and Cardiovascular Disease and Stroke